A Feasibility Study of Group-Delivered Behavioral Interventions for Insomnia among Breast Cancer Survivors: Comparing Cognitive Behavioral Therapy for Insomnia and a Mind-Body Intervention
Journal of Alternative and Complementary Medicine, ISSN: 1557-7708, Vol: 25, Issue: 8, Page: 840-844
2019
- 7Citations
- 51Usage
- 94Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations7
- Citation Indexes7
- Usage51
- Abstract Views51
- Captures94
- Readers94
- 94
Article Description
Objectives: An estimated 30%-50% of breast cancer survivors (BCSs) report persistent insomnia, which may affect daytime functioning and quality of life, and lead to longer term health complications. Although the gold standard insomnia intervention, cognitive behavioral therapy for insomnia (CBT-I), has demonstrated efficacy, accessibility is limited due to a scarcity of trained providers, and adherence to therapy is variable. Group-delivered alternative therapies may offer an opportunity to reach and treat BCSs with insomnia. This pilot study was designed to assess feasibility of a group-delivered mind-body intervention compared with group-delivered CBT-I among BCSs. Design: The authors recruited n = 25 stages I-IV BCSs to a 9-week trial of group therapy for insomnia. Eligible women were assigned to the next upcoming group until it was full. Primary outcomes were to assess intervention feasibility measured by (1) qualitative focus group feedback and (2) attendance. The feasibility of using the Insomnia Severity Index (ISI) was also assessed in this population and ISI change scores were gathered to allow for power calculations in a future trial. Means and frequencies were used to describe participant demographics and attendance. Results: The authors found higher attendance (86% vs. 67% of sessions) and greater satisfaction with the intervention (84.6% vs. 57.1%) reported among mind-body participants than among CBT-I participants. Qualitative feedback suggested more group cohesion among the mind-body group and lower incentive to attend in-person among the CBT-I group. Conclusions: The results suggest that delivering a mind-body intervention for BCSs is feasible and acceptable, based on attendance and qualitative feedback.
Bibliographic Details
https://hsrc.himmelfarb.gwu.edu/sphhs_epibiostats_facpubs/618; https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/4393
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85070809215&origin=inward; http://dx.doi.org/10.1089/acm.2019.0038; http://www.ncbi.nlm.nih.gov/pubmed/31237434; https://www.liebertpub.com/doi/10.1089/acm.2019.0038; https://hsrc.himmelfarb.gwu.edu/sphhs_epibiostats_facpubs/618; https://hsrc.himmelfarb.gwu.edu/cgi/viewcontent.cgi?article=1619&context=sphhs_epibiostats_facpubs; https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/4393; https://hsrc.himmelfarb.gwu.edu/cgi/viewcontent.cgi?article=5416&context=smhs_medicine_facpubs; https://dx.doi.org/10.1089/acm.2019.0038
Mary Ann Liebert Inc
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know